Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZKJT for concurrent chemoradiotherapy in oral cavity cancer
NCT05590650Phase 1Completed
- Sponsor
- China Medical University Hospital
- Start
- Jul 2018
- Primary completion
- Jun 2020
- Modality
- TCM (Traditional Chinese Medicine), HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of San-Zhong-Kui-Jian-Tang in head and neck cancer (HNC), sponsored by China Medical University Hospital. Primary endpoint: CCRT completion rate at 7 weeks. Started Jul 2018; status: completed.
02
Drugs
San-Zhong-Kui-Jian-Tang
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT05590650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590650.